Pfizer advances pivotal paediatric pneumococcal va...
Category : Clinical Trial Update 22 May 2026Pfizer Inc. announced data from its phase 2 study (NCT06524414) evaluating the safety, tolerability...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
UCB reports positive outcomes for bimekizumab in p...
Category : Clinical Trial Update 22 May 2026Trial shows first head‑to‑head superiority in joint endpoints for an approved PsA biologic UCB has...
US FDA accepts and grants priority review status t...
Category : Clinical Trial Update 22 May 2026Bayer announced that the US Food and Drug Administration (FDA) has accepted its supplemental New Dru...
Orexo announces positive data from an in-vivo stud...
Category : Clinical Trial Update 21 May 2026Orexo AB (publ.), a Swedish pharmaceutical company dedicated to advance treatments for severe diseas...
ElevAATe phase 2 data demonstrate the superiority...
Category : Clinical Trial Update 21 May 2026Data from the global ElevAATe phase 2 study (clinical study identifier: NCT05856331) demonstrated su...
Latest Newsletter Post
-
US FDA accepts and grants priority..
22 May 2026
-
UCB reports positive outcomes for b..
22 May 2026
-
Pfizer advances pivotal paediatric..
22 May 2026
-
Mabylon reports positive phase Ia r..
21 May 2026
-
InMed Pharma & Mentari Therapeutics..
21 May 2026
